Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-valeant-joseph-papa.jpg" NAME"Valeant Plummets After Revealing Jaw-Dropping Payday For Its CEO" ALT"Valeant Plummets After Revealing Jaw-Dropping Payday For Its CEO"April 5, 2017By Alex Keown, BioSpace.com Breaking News Staff... Source: BioSpace

Continue ReadingValeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

Data To Be Presented At Highlighting GENFIT???s Latest Progress In NASH Biomarker Diagnostics, Identifying Novel Compounds With Potent Antifibrotic Properties, And Illustrating The Opportunities In Anti-NASH Drug Combinations

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingData To Be Presented At Highlighting GENFIT???s Latest Progress In NASH Biomarker Diagnostics, Identifying Novel Compounds With Potent Antifibrotic Properties, And Illustrating The Opportunities In Anti-NASH Drug Combinations

Astellas Takes Out Belgium Biotech in Deal Worth $853 Million

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astellas.jpg" NAME"Astellas Takes Out Belgium Biotech in Deal Worth $853 Million" ALT"Astellas Takes Out Belgium Biotech in Deal Worth $853 Million"April 3, 2017By Alex Keown, BioSpace.com Breaking News StaffTOKYO...…

Continue ReadingAstellas Takes Out Belgium Biotech in Deal Worth $853 Million